Novartis names Bulto head of U.S. pharma 

Novartis has appointed Victor Bulto as head of its U.S. pharmaceuticals business, effective September 1. He is set to replace Fabrice Chouraqui, who is planning to step down at the end of this month, according to Reuters

GSK changes US leadership 

GlaxoSmithKline has named Maya Martinez-Davis, regional president for Latin America at EMD Serono, Merck KGaA’s biopharmaceutical business, as president of U.S. pharmaceuticals. She will replace Jack Bailey, who will step down at the end of this year.  

Ogilvy Health ups seven 

Ogilvy Health has promoted seven in its New York and New Jersey offices. The firm has named Mike Brune and Deborah Ciauro as executive creative director; Larry Hannon as SVP and creative director; Beth Elkis and George Giunta as group creative directors; Anita Carusa as VP and associate creative director; and Agnes Topor as associate creative director. 

Molinaro joins FCB Health Network

FCB Health Network has hired Suzanne Molinaro as director of production, a newly created role overseeing broadcast production and services across the network. She will also manage integrated production and regulatory operations for FCB Health New York, Mosaic Group, ProHealth and FCBVIO. 

Hill joins Alzheimer’s Association 

The Alzheimer’s Association has hired Dr. Carl Hill as VP of scientific engagement, responsible for promoting its international research program and launching initiatives for public health and engaging physicians. He was previously director of the office of special populations in the National Institutes of Aging at the National Institutes of Health. 

Smith joins Jarrard Phillips Cate & Hancock

Healthcare comms consultancy Jarrard Phillips Cate & Hancock has hired Reed Smith to grow the firm’s capabilities in digital. Smith previously oversaw product development for the Texas Hospital Association among other roles.

Prime Therapeutics hires McGrail-Pokuta

Prime Therapeutics has hired Kelly McGrail-Pokuta as VP of pharmacy trade relations, overseeing strategic direction and management of all pharmaceutical manufacturer relationships in support of its total drug management business model. She has worked at OptumRx, Diplomat Pharmacy and CVS Caremark. 

LavoieHealthScience promotes two

LaVoieHealthScience has promoted Sharon Correia to EVP of integrated communications and chief strategy officer and Ella Deych as VP of finance and COO, the agency’s first executive overseeing two two areas.

PCMA adds four 

The Pharmaceutical Care Management Association has brought on four staffers. The organization hired Jocelyn Wiles as senior director of federal affairs; Heather Cascone as senior director of state affairs; Mike Baldyga as director in PCMA’s strategic communications department; and Kayla Firriolo as conference manager. 

Client-side people moves courtesy of MM&M sister brand The PMD.

Azurity Pharmaceuticals has named Ronald Scarboro as COO and CFO; Se-Se Yennes as VP of corporate strategy and new product planning; Nicole Frederickson as VP of marketing; and Dave Quadros as VP of operations. 

BioDuro has appointed David Hedden as chief scientific officer; and Sam Bhattacharya as marketing manager. 

Merz North America has named Diala Jallad as marketing coordinator; Michael Floegel as VP of sales; Paige Davis as brand manager for aesthetics; Casey Croom as associate product manager for Neocutis; Manasi Ramanna as VP of financial planning analysis and operations; Bill Edwards as VP and general counsel; Jeffrey Ho as global brand manager; Jonathan Parrish as VP of commercial development for North America; and Matt Anderson as VP and head of technical operations for North America. 

Stoke Therapeutics has appointed Edward Kaye as CEO; Huw Nash as chief operating and business officer; Barry Ticho as chief medical officer; Stephen Tulipano as CFO; Gene Liau as EVP and head of research and preclinical development; Isabel Aznarez as cofounder, VP and head of biology; Dawn Kalmar as VP and head of corporate affairs; Shamim Ruff as SVP of RA & QA; Nancy Wyant as VP and head of clinical operations. 

Strongbridge Biopharma has named Richard Kollender as COO. 

Bellerophon Therapeutics has appointed Martin Dekker as VP of engineering and manufacturing. 

Biohaven Pharmaceuticals has named Robert Croop as chief development officer for neurology; Courtney Cupples as SVP of commercial strategy and marketing; Mark Glackin as VP of migraine sales and marketing; William Jones as chief commercial officer for migraine and common disease; Loren Aguiar as VP for research and development; Adrienne Ross as VP for commercialization migraine; and Cliff Bechtold as COO. 

Midmark has appointed Jerry Stahl as VP of corporate accounts; Stephanie Muir as chief technology officer; Kurt Forsthoefel as marketing director; Jenny Puthoff as marketing initiatives supervisor; Tom Schweiterman as chief medical officer; Sue Hulsmeyer as VP of human resources and corporate communication. 

NeuroPace has named Clare Carron as director of product marketing. 

PTC Therapeutics has appointed Chris Seagle as VP and head of global market access. 

Assembly Biosciences has named John McHutchinson as CEO.

BioTelemetry has appointed Dave Bliss as VP and general manager of BioTel Care and Tim Raher as SVP of human resources.

Biotest Pharmaceuticals has named Awilda Orta-Gerber as head of quality and regulatory affairs. 

MilliporeSigma has appointed Pauline Collins as head, marcom services manager; Vernica Fineberg as marketing communications specialist; Renee Connolly as head of communications and corporate responsibility; Stephanie McGary as head of marketing bioprocessing; and Stephen Karel as chief business officer. 

The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Frank Washkuch at